Cameri, Italy

Alberto Lena

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Procos Gmbh. Active years: 2024.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Alberto Lena

Introduction

Alberto Lena is a notable inventor based in Cameri, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of midostaurin, a drug used in cancer treatment. His innovative approach has led to advancements in the purity and efficacy of this important medication.

Latest Patents

Alberto Lena holds a patent for a process titled "Process for the preparation of midostaurin with high purity." This patent describes a method that ensures a content of oxidation impurities lower than 0.1%. The process involves treating crude midostaurin or staurosporine with strong organic or inorganic acids in a water-immiscible solvent, and optionally, with reducing silanes. This innovation is crucial for enhancing the quality of midostaurin, making it safer and more effective for patients.

Career Highlights

Lena is currently associated with Procos GmbH, a company that specializes in pharmaceutical development and manufacturing. His work at Procos GmbH has allowed him to focus on improving drug formulations and processes, contributing to the advancement of medical science.

Collaborations

Throughout his career, Alberto Lena has collaborated with talented professionals such as Antonio Toppino and Katia Miele. These collaborations have fostered a creative environment that encourages innovation and the sharing of ideas.

Conclusion

Alberto Lena's contributions to the field of pharmaceuticals, particularly through his patent for midostaurin preparation, highlight his role as an influential inventor. His work continues to impact the medical community positively, ensuring better treatment options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…